1型戈谢病患者的血小板功能和凝血异常：酶替代疗法（ERT）的效果 - Suppr

Suppr

超能文献

Platelet function and coagulation abnormalities in type 1 Gaucher disease patients: effects of enzyme replacement therapy (ERT).

作者信息

Giona F, Palumbo G, Amendola A, Santoro C, Mazzuconi M G

出版信息

J Thromb Haemost. 2006 Aug;4(8):1831-3. doi: 10.1111/j.1538-7836.2006.02037.x.

DOI:10.1111/j.1538-7836.2006.02037.x

PMID:16879228

Abstract

摘要

相似文献

Platelet function and coagulation abnormalities in type 1 Gaucher disease patients: effects of enzyme replacement therapy (ERT).

J Thromb Haemost. 2006 Aug;4(8):1831-3. doi: 10.1111/j.1538-7836.2006.02037.x.

Platelet function defects in patients with Gaucher disease on long term ERT- implications for evaluation at bleeding challenges.

Blood Cells Mol Dis. 2020 Feb;80:102371. doi: 10.1016/j.bcmd.2019.102371. Epub 2019 Oct 18.

Haemostatic abnormalities in treatment-naïve patients with Type 1 Gaucher's disease.

Platelets. 2012;23(2):143-9. doi: 10.3109/09537104.2011.597526. Epub 2011 Jul 19.

Platelet function abnormalities in Gaucher disease patients.

Am J Hematol. 1999 Jun;61(2):103-6. doi: 10.1002/(sici)1096-8652(199906)61:2<103::aid-ajh5>3.0.co;2-v.

Markers of coagulation activation and enhanced fibrinolysis in Gaucher type 1 patient: Effects of enzyme replacement therapy.

Blood Cells Mol Dis. 2012 Jun 15;49(1):58-9. doi: 10.1016/j.bcmd.2012.03.003. Epub 2012 Mar 27.

Changes in serum chitotriosidase activity with cessation of replacement enzyme (cerebrosidase) administration in Gaucher disease.

Clin Biochem. 2000 Mar;33(2):147-9. doi: 10.1016/s0009-9120(99)00098-3.

Enzyme replacement therapy for Gaucher disease in Australia.

Intern Med J. 2005 Mar;35(3):156-61. doi: 10.1111/j.1445-5994.2004.00765.x.

Cessation of enzyme replacement therapy in Gaucher disease.

Genet Med. 2002 Nov-Dec;4(6):427-33. doi: 10.1097/00125817-200211000-00005.

Histologic findings of femoral heads from patients with Gaucher disease treated with enzyme replacement.

Am J Clin Pathol. 2013 Jul;140(1):91-6. doi: 10.1309/AJCPFVSAEGO67NGT.

A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase.

Blood Cells Mol Dis. 2014 Dec;53(4):253-60. doi: 10.1016/j.bcmd.2014.05.004. Epub 2014 Jun 18.

引用本文的文献

Hemostatic Abnormalities in Gaucher Disease: Mechanisms and Clinical Implications.

J Clin Med. 2022 Nov 24;11(23):6920. doi: 10.3390/jcm11236920.

Brain-Derived Neurotrophic Factor (BDNF) Is Associated with Platelet Activity and Bleeding Tendency in Patients with Gaucher Disease.

Int J Mol Sci. 2022 Nov 12;23(22):13982. doi: 10.3390/ijms232213982.

Novel Management and Screening Approaches for Haematological Complications of Gaucher's Disease.

J Blood Med. 2021 Dec 7;12:1045-1056. doi: 10.2147/JBM.S279756. eCollection 2021.

Coagulation Parameters in Adult Patients With Type-1 Gaucher Disease.

J Hematol. 2019 Sep;8(3):121-124. doi: 10.14740/jh543. Epub 2019 Sep 30.

Reno-protection of G004, a novel anti-diabetic sulfonylurea in db/db mice.

Naunyn Schmiedebergs Arch Pharmacol. 2015 Aug;388(8):831-41. doi: 10.1007/s00210-015-1112-7. Epub 2015 May 6.

Hemorrhagic aspects of Gaucher disease.

Rambam Maimonides Med J. 2014 Oct 29;5(4):e0039. doi: 10.5041/RMMJ.10173. eCollection 2014 Oct.

Recommendations for the management of the haematological and onco-haematological aspects of Gaucher disease.

Br J Haematol. 2007 Sep;138(6):676-86. doi: 10.1111/j.1365-2141.2007.06701.x. Epub 2007 Jul 26.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Platelet function and coagulation abnormalities in type 1 Gaucher disease patients: effects of enzyme replacement therapy (ERT).

作者信息

Giona F, Palumbo G, Amendola A, Santoro C, Mazzuconi M G

出版信息

J Thromb Haemost. 2006 Aug;4(8):1831-3. doi: 10.1111/j.1538-7836.2006.02037.x.

DOI:10.1111/j.1538-7836.2006.02037.x

PMID:16879228

Abstract

摘要

相似文献

Platelet function and coagulation abnormalities in type 1 Gaucher disease patients: effects of enzyme replacement therapy (ERT).

J Thromb Haemost. 2006 Aug;4(8):1831-3. doi: 10.1111/j.1538-7836.2006.02037.x.

Platelet function defects in patients with Gaucher disease on long term ERT- implications for evaluation at bleeding challenges.

Blood Cells Mol Dis. 2020 Feb;80:102371. doi: 10.1016/j.bcmd.2019.102371. Epub 2019 Oct 18.

Haemostatic abnormalities in treatment-naïve patients with Type 1 Gaucher's disease.

Platelets. 2012;23(2):143-9. doi: 10.3109/09537104.2011.597526. Epub 2011 Jul 19.

Platelet function abnormalities in Gaucher disease patients.

Am J Hematol. 1999 Jun;61(2):103-6. doi: 10.1002/(sici)1096-8652(199906)61:2<103::aid-ajh5>3.0.co;2-v.

Markers of coagulation activation and enhanced fibrinolysis in Gaucher type 1 patient: Effects of enzyme replacement therapy.

Blood Cells Mol Dis. 2012 Jun 15;49(1):58-9. doi: 10.1016/j.bcmd.2012.03.003. Epub 2012 Mar 27.

Changes in serum chitotriosidase activity with cessation of replacement enzyme (cerebrosidase) administration in Gaucher disease.

Clin Biochem. 2000 Mar;33(2):147-9. doi: 10.1016/s0009-9120(99)00098-3.

Enzyme replacement therapy for Gaucher disease in Australia.

Intern Med J. 2005 Mar;35(3):156-61. doi: 10.1111/j.1445-5994.2004.00765.x.

Cessation of enzyme replacement therapy in Gaucher disease.

Genet Med. 2002 Nov-Dec;4(6):427-33. doi: 10.1097/00125817-200211000-00005.

Histologic findings of femoral heads from patients with Gaucher disease treated with enzyme replacement.

Am J Clin Pathol. 2013 Jul;140(1):91-6. doi: 10.1309/AJCPFVSAEGO67NGT.

Blood Cells Mol Dis. 2014 Dec;53(4):253-60. doi: 10.1016/j.bcmd.2014.05.004. Epub 2014 Jun 18.

引用本文的文献

Hemostatic Abnormalities in Gaucher Disease: Mechanisms and Clinical Implications.

J Clin Med. 2022 Nov 24;11(23):6920. doi: 10.3390/jcm11236920.

Brain-Derived Neurotrophic Factor (BDNF) Is Associated with Platelet Activity and Bleeding Tendency in Patients with Gaucher Disease.

Int J Mol Sci. 2022 Nov 12;23(22):13982. doi: 10.3390/ijms232213982.

Novel Management and Screening Approaches for Haematological Complications of Gaucher's Disease.

J Blood Med. 2021 Dec 7;12:1045-1056. doi: 10.2147/JBM.S279756. eCollection 2021.

Coagulation Parameters in Adult Patients With Type-1 Gaucher Disease.

J Hematol. 2019 Sep;8(3):121-124. doi: 10.14740/jh543. Epub 2019 Sep 30.

Reno-protection of G004, a novel anti-diabetic sulfonylurea in db/db mice.

Naunyn Schmiedebergs Arch Pharmacol. 2015 Aug;388(8):831-41. doi: 10.1007/s00210-015-1112-7. Epub 2015 May 6.

Hemorrhagic aspects of Gaucher disease.

Rambam Maimonides Med J. 2014 Oct 29;5(4):e0039. doi: 10.5041/RMMJ.10173. eCollection 2014 Oct.

Recommendations for the management of the haematological and onco-haematological aspects of Gaucher disease.

Br J Haematol. 2007 Sep;138(6):676-86. doi: 10.1111/j.1365-2141.2007.06701.x. Epub 2007 Jul 26.